Arrakis Inks First Partnership In RNA-Targeted Collaboration With Roche

 
• By Joseph Haas

Biotech gets $190m up front in partnership that will discover small molecule RNA-targeted therapies against a range of targets selected by Roche. Arrakis thinks its technology can drug difficult-to-reach targets.

Two businessmen shaking hands during a meeting in the office, success, dealing, greeting & business partner concepts - soft light.
Collaboration with Roche is Arrakis' first partnership after years of fine-tuning its technology

More from Deals

More from Business